-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Karyopharm Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2018 to Q1 2024.
- Karyopharm Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$43.7M, a 131% decline year-over-year.
- Karyopharm Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$92.7M, a 38% increase from 2022.
- Karyopharm Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$150M, a 39.6% decline from 2021.
- Karyopharm Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$107M, a 33.2% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)